Serogroup W meningococcal disease: Global spread and current affect on the Southern Cone in Latin America

Epidemiology and Infection

Volumn 142, Issue 12, 2014, Pages 2461-2470

  Abad, R ^a   Lopez E L ^b   Debbag, R ^c   Vazquez J A ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

^c Sanofi Pasteur Medical Department for Latin America   (Argentina)

Author keywords

Meningococcal disease; meningococcus (N. meningitidis); molecular epidemiology

Indexed keywords

ARGENTINA; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIUM ISOLATION; BRAZIL; CHILE; CLONAL SPECIES; EPIDEMIC; GENETIC DRIFT; GENETIC VARIABILITY; GEOGRAPHIC DISTRIBUTION; HUMAN; INCIDENCE; INFECTION RATE; INFECTION SENSITIVITY; MENINGOCOCCOSIS; MOLECULAR EVOLUTION; MORTALITY; NONHUMAN; REVIEW; SEROTYPE; SOUTH AND CENTRAL AMERICA; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; EPIDEMIOLOGY; HEALTH; IMMUNOLOGY; MENINGOCOCCAL INFECTIONS; MICROBIOLOGY; NEISSERIA MENINGITIDIS; PREVENTIVE HEALTH SERVICE;

MENINGOCOCCUS VACCINE;

ARGENTINA; BRAZIL; CHILE; COMMUNICABLE DISEASES, EMERGING; DISEASE OUTBREAKS; GLOBAL HEALTH; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; NEISSERIA MENINGITIDIS, SEROGROUP W-135;

EID: 84911981434     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814001149     Document Type: Review

References (54)

1. Harrison LH, Trotter CL, Ramsay ME. Global epidemiology of meningococcal disease. Vaccine 2009; 27 (Suppl. 2): B51-B63.
2. Sáfadi MA, et al. The epidemiology of meningococcal disease in Latin America 1945-2010: an unpredictable and changing landscape. Epidemiology and Infection 2012; 9: 1-12.
3. Abad R, et al. Molecular characterization of invasive serogroup Y Neisseria meningitidis strains isolated in the Latin America region. Journal of Infection 2009; 59: 104-114.
4. Bröker M, et al. Increase of meningococcal serogroup Y cases in Europe: a reason for concern? Human Vaccines and Immunotherapeutics 2012; 8: 685-688.
5. Caugant DA, et al. (2012). Molecular characterization of invasive meningococcal isolates from countries in the African meningitis belt before introduction of a serogroup A conjugate vaccine. PLoS One 2012; 7: e46019.
6. Mayer LW, et al. Outbreak of W meningococcal disease in 2000: not emergence of a new W strain but clonal expansion within the electrophoretic type-37 complex. Journal of Infectious Diseases 2002; 185: 1596-1605.
7. Griffiss JM, Brandt BL. Disease due to serogroup W Neisseria meningitidis. Pediatrics 1979; 64: 218-221.
8. Kwara A, et al. Meningitis caused by a serogroup W clone of the ET37 complex of Neisseria meningitidis in West Africa. Tropical Medicine and International Health 1998; 3: 742-746.
9. Popovic T, et al. Neisseria meningitidis serogroup Wisolates associated with the ET37 complex. Emerging Infectious Diseases 2000; 6: 428-429.
10. Hahné SJ, et al. W meningococcal disease in England and Wales associated with Hajj 2000 and 2001. Lancet 2002; 359: 582-583.
11. Taha MK, et al. Continuing diversification of Neisseria meningitidisWas a primary cause of meningococcal disease after emergence of the serogroup in 2000. Journal of Clinical Microbiology 2004; 42: 4158-4163.
12. Taha MK, et al. Neisseria meningitidis serogroups W and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger. Journal of Clinical Microbiology 2002; 40: 1083-1084.
13. Koumaré B, et al. The first large epidemic of meningococcal disease caused by serogroup W, Burkina Faso, 2002. Vaccine 2007; 25 (Suppl. 1), A37-41.
14. MacLennan JM, et al. Carriage of serogroup W, ET37 meningococci in the Gambia: implications for immunisation policy. Lancet 2000; 356: 1078.
15. Kristiansen PA, et al. Phenotypic and genotypic characterization of meningococcal carriage and disease isolates in Burkina Faso after mass vaccination with a serogroup a conjugate vaccine. BMC Infectious Diseases 2013; 13: 363.
16. Wilder Smith A, et al. Persistence of W Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts. Emerging Infectious Diseases 2003; 9: 123-126.
17. Nicolas P, et al. Pharyngeal carriage of serogroup W Neisseria meningitidis in Hajjees and their family contacts in Morocco, Oman and Sudan. APMIS 2005; 113: 182-186.
18. Ceyhan M, et al. Acquisition of meningococcal serogroup W-135 carriage in Turkish Hajj pilgrims who had received the quadrivalent meningococcal polysaccharide vaccine. Clinical and Vaccine Immunology 2013; 20: 66-68.
19. Wilder-Smith A, Chow A, Goh KT. Emergence and disappearance of W meningococcal disease. Epidemiology & Infection 2009; 138: 976-978.
20. Parent du Châtelet I, Barboza P, Taha MK. W invasive meningococcal infections imported from Sub-Saharan Africa to France, January to April 2012. Eurosurveillance 2012; 17: pii=20181.
21. Collard JM, et al. Increase in Neisseria meningitidis serogroup W, Niger, 2010. Emerging Infectious Diseases 2010; 16: 1496-1498.
22. Frasch CE, Preziosi MP, LaForce FM. Development of a group A meningococcal conjugate vaccine, MenAfriVac™. Human Vaccines and Immunotherapeutics 2012; 8: 715-724.
23. World Health Organization. Meningococcal disease: situation in the African Meningitis Belt (http://www. who.int/csr/don/2012-05-24/en/index.html). Accessed 28 July 2013
24. Djingareya MH, et al. Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience. Vaccine 2012; 30 (Suppl. 2): B40-B45.
25. Daugla DM, et al. Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial. Lancet. Published online 11 September 2013. doi:10.1016/S0140-6736(13)61612-8.
26. Kristiansen PA, et al. Impact of the serogroup A meningococcal conjugate vaccine, MenAfriVac, on carriage and herd immunity. Clinical Infectious Diseases 2013; 56: 354-363.
27. von Gottberg A. Neisseria meningitidis. Communicable Diseases Surveillance Bulletin 2012; 10: 60-63.
28. von Gottberg A, et al. Emergence of endemic serogroup W meningococcal disease associated with a high mortality rate in South Africa. Clinical Infectious Diseases 2008; 46: 377-386.
29. Ministry of Health Portal. Kingdom of Saudi Arabia. Basic vaccination schedule (http://www.moh.gov.sa/en/ HealthAwareness/EducationalContent/HealthTips/Pages/ Tips-005.aspx). Accessed 26 July 2013.
30. Weidlich L et al. High prevalence of Neisseria meningitidis hypervirulent lineages and emergence of W:P15,2: ST11 clone in Southern Brazil. Journal of Infection 2008; 57: 324-331.
31. Barroso DE, Rebelo MC. Recognition of the epidemiological significance of Neisseria meningitidis capsular serogroup W in the Rio de Janeiro region, Brazil. Memórias do Instituto Oswaldo Cruz 2007; 102: 773-775.
32. López EL, Debbag R. Meningococcal disease: always present. Serogroup changes in the Southern Cone. Revista Chilena de Infectología 2012; 29: 587-594.
33. Lemos AP, et al. Phenotypic and molecular characterization of invasive serogroup W Neisseria meningitidis strains from 1990 to 2005 in Brazil. Journal of Infection 2009; 60: 209-217.
34. Ferreira E, et al. Neisseria meningitidis serogroup W in Portugal - presence of the ST11/ET37 clonal complex. Pathologie Biologie 2007; 56:94
35. Ibarz-Pavón AB, et al. Laboratory-based surveillance of Neisseria meningitidis isolates from disease cases in Latin American and Caribbean countries, SIREVA II 2006-2010. PLoS One 2012; 7: e 44102.
36. Efron AM, et al. Significant increase of serogroup W invasive Neisseria meningitidis strains in Argentina: a new epidemiological feature on the region. Sixteenth International Pathogenic Conference 2008, Rotterdam, The Netherlands. P-169. (http://neisseria.org/ipnc/2008/ Abstracts-poster-presentations-IPNC-2008.pdf). Accessed 28 July 2013.
37. Efron AM, et al. W invasive meningococcal strains spreading in South America: significant increase in incidence rate in Argentina. Journal of Clinical Microbiology 2009; 47: 1979-1980.
38. Sorhouet-Pereira C, et al. Phenotypic and genotypic characteristics of Neisseria meningitidis diseasecausing strains in Argentina, 2010. PLoS One 2013; 8: e 58 065.
39. Ministerio Salud Pública Republica de Chile. Situation of meningococcal disease caused by serogroup W (http://epi.minsal.cl/epi/html/bolets/reportes/Meningitis/W-Web-SE46A.pdf) Accessed 26 July 2013.
40. Barra GN, et al. Molecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011. PLoS One 2013; 8: e 66006.
41. Ministerio Salud Pública Republica de Chile. Action Plan W (http://www.minsal.gob.cl/portal/url/ page/minsalcl/g-varios/boletin/meningitis/page-1.html). Accessed 26 July 2013.
42. Ministerio Salud Pública Republica de Chile. Meningococcal disease (CIE-10: A39). Epidemiological situation, January-December, 2013. Action Plan W-135 (http://epi.minsal.cl/epi/html/AtlasInteractivos/AtlasBET/ ABET-04/EM-BET4.pdf) Accessed 22 January 2014.
43. Cohn AC, Harrison LH. Meningococcal vaccines: current issues and future strategies. Drugs 2013; 73: 1147-1155.
44. Ministerio Salud Pública Republica de Chile. Research on carriage of Neisseria meningitidis (http:// web.minsal.cl/portal/url/page/minsalcl/g-varios/boletin/ meningitis/page-6.html. Accessed 22 January 2014.
45. Instituto de Salud Pública de Chile. Report of the results of laboratory surveillance. invasive disease. Neisseria meningitidis 2012. (http://www.ispch.cl/sites/default/ files/Informe%20N.m%202012.pdf). Accessed 26 July 2013.
46. Taha MK, et al. Serogroup W meningococcal disease in Hajj pilgrims. Lancet 2000; 356: 2159.
47. Taha MK, et al. Travel-related Neisseria meningitidis serogroup W135 infection, France. Emerging Infectious Diseases 2013; 19: 1030-1032.
48. Doyle TJ, et al. Cluster of serogroup W135 meningococci, southeastern Florida, 2008-2009. Emerging Infectious Diseases 2010; 16: 113-115.
49. Jones DM, Sutcliffe EM. Group A meningococcal disease in England associated with the Hajj. Journal of Infection 1990; 21: 21-25.
50. Al-Gahtani YM, et al. Epidemiological investigation of an outbreak of meningococcal meningitis in Makkah (Mecca), Saudi-Arabia, 1992. Epidemiology & Infection 1995; 115: 399-409.
51. Wang JF, et al. Antigenic and epidemiologic properties of the ET37 complex of Neisseria meningitidis. Journal of Infectious Diseases 1993; 167: 1320-1329.
52. Castilla J, et al. B:2a:P15 meningococcal strains likely arisen from capsular switching event still spreading in Spain. Journal of Clinical Microbiology 2009; 47: 463-465.
53. du Plessis M, et al. Whole genome resolution of selected Neisseria meningitidis serogroupWstrains, South Africa, 2003-2012. 12th EMGM 2013, Bad Loipersdorf, Austria. P-097 (http://emgm.eu/meetings/emgm2013/ Abstract-Book-EMGM-2013.pdf). Accessed 28 July 2013.
54. Zhou H, et al. Spread of Neisseria meningitidis serogroup W clone, China. Emerging Infectious Diseases 2013; 19: 1496-1469.